Skip to main content
Premium Trial:

Request an Annual Quote

Surface Logix, Maven Technologies, BioMerieux

Premium

Surface Logix of Brighton, Mass., has received US Patent No. 7,001,740, "Methods of arraying biological materials using peelable and resealable devices." The patent claims devices and methods for performing assays on biological materials. The devices and methods make use of self-sealing members, which can be applied to a flat surface to form wells to facilitate immobilization of materials on the flat surface, then removed to yield a flat surface that facilitates the performance of processes on and detection of the immobilized material, according to the patent's abstract. According to the patent, the devices that make use of these methods may include spatial arrays and microtiter plates.


Maven Technologies of Los Angeles, has received US Patent No. 7,002,686, "Apparatus and method for imaging." The patent claims a microarray that is useful in applications that utilize local polarization changes detected in respective parts of an emerging light beam. The patent claims this augments the methods described in US Patent No. 5,633,724, "Evanescent scanning of biochemical array", assigned to Hewlett-Packard, which describes the readout of a biochemical array using the evanescent field, and using the evanescent field to excite fluorescent markers attached to the substances to be detected and analyzed.


BioMerieux of Marcy L'Etoile, France, has received US Patent No. 7,001,572, "Analyzing device with biochip." The patent claims a device for an analyte, comprising a container and a biochip that are attached at least one section. The patent's abstract states further claims that the biochip is fixed by adhesive to the container in a way that the peripheral zone of the active face of the biochip is exposed.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.